Stay updated on Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page.

Latest updates to the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new Locations section now lists Kentucky, Missouri, and Pennsylvania, replacing the previous Kentucky Locations, Missouri Locations, and Pennsylvania Locations subsections. The HHS Vulnerability Disclosure link in the footer was removed.SummaryDifference0.5%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedPublications section updated to note that entries are automatically filled from PubMed. Revision number updated to v3.3.2.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the government funding lapse notice about data currency. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedNo additions or deletions were observed between the screenshots; the study details page content and structure appear unchanged.SummaryDifference0.5%

- Check92 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference4%

- Check99 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page.